IMF Virtual Regional Community Workshop (RCW) - Southern Region
Virtual Multiple Myeloma Community Workshop
A virtual multiple myeloma workshop addressing the needs specific to communities in the Southern region.
The IMF Virtual Regional Community Workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. A member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.
Saturday, October 2, 2021
10:00 – 12:30 PM Central Time
Welcome and Announcements
Kelly Cox, Senior Director IMF Regional Community Workshops
Myeloma 101 and Frontline Therapy
Siddhartha Ganguly, MD, FACP (Houston Methodist) reviews multiple myeloma basics including what myeloma is, common symptoms and side effects, advances in how myeloma is initially diagnosed, the stages of myeloma treatment, induction therapy, transplant, and more.
Relapsed Therapy and Clinical Trials
Rafat Abonour, MD (Indiana University Health) discusses the types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, updates on clinical trials, and more.
Managing Multiple Myeloma symptoms and treatment side effects
Ann McNeill, RN, MSN, APN (IMF Nurse Leadership Board) discusses how patients can manage myeloma-related symptoms and side effects along with side effects brought on by treatment. She outlines the most common side effects for each myeloma drug category, how to prevent infection, and more.
Download the IMF's Multiple Myeloma Informational Booklets:
With Support From: Amgen, Bristol Myers Squibb, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, Takeda Oncology and The Binding Site
||Even the Odds|